CN101543298B - Rutin chewing agent and method for preparing same - Google Patents
Rutin chewing agent and method for preparing same Download PDFInfo
- Publication number
- CN101543298B CN101543298B CN2009100589496A CN200910058949A CN101543298B CN 101543298 B CN101543298 B CN 101543298B CN 2009100589496 A CN2009100589496 A CN 2009100589496A CN 200910058949 A CN200910058949 A CN 200910058949A CN 101543298 B CN101543298 B CN 101543298B
- Authority
- CN
- China
- Prior art keywords
- rutin
- chewing
- oil
- mesh sieves
- diluent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 title claims abstract description 91
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 title claims abstract description 91
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 title claims abstract description 91
- 235000005493 rutin Nutrition 0.000 title claims abstract description 91
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 title claims abstract description 91
- 229960004555 rutoside Drugs 0.000 title claims abstract description 91
- 238000000034 method Methods 0.000 title claims abstract description 17
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 title claims abstract 18
- 230000001055 chewing effect Effects 0.000 title abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 42
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 21
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 21
- 239000011718 vitamin C Substances 0.000 claims abstract description 21
- 239000002245 particle Substances 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 7
- 239000003826 tablet Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000003085 diluting agent Substances 0.000 claims description 17
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 11
- 239000008101 lactose Substances 0.000 claims description 11
- 239000011122 softwood Substances 0.000 claims description 11
- 239000000314 lubricant Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 9
- 239000000853 adhesive Substances 0.000 claims description 9
- 230000001070 adhesive effect Effects 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 9
- 235000014101 wine Nutrition 0.000 claims description 9
- 239000000811 xylitol Substances 0.000 claims description 9
- 235000010447 xylitol Nutrition 0.000 claims description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 9
- 229960002675 xylitol Drugs 0.000 claims description 9
- 239000007910 chewable tablet Substances 0.000 claims description 8
- 235000015111 chews Nutrition 0.000 claims description 8
- 239000000080 wetting agent Substances 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 235000020985 whole grains Nutrition 0.000 claims description 7
- 101100433727 Caenorhabditis elegans got-1.2 gene Proteins 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- -1 sorbierite Chemical compound 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 239000006188 syrup Substances 0.000 claims description 6
- 235000020357 syrup Nutrition 0.000 claims description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 241000167854 Bourreria succulenta Species 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 240000008790 Musa x paradisiaca Species 0.000 claims description 3
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 3
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 3
- 235000019502 Orange oil Nutrition 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- 239000004568 cement Substances 0.000 claims description 3
- 235000019693 cherries Nutrition 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 239000000686 essence Substances 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 3
- 229960002160 maltose Drugs 0.000 claims description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 239000010502 orange oil Substances 0.000 claims description 3
- 235000019477 peppermint oil Nutrition 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 9
- 239000000654 additive Substances 0.000 abstract description 4
- 230000000996 additive effect Effects 0.000 abstract description 4
- 238000004090 dissolution Methods 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 208000019505 Deglutition disease Diseases 0.000 abstract 1
- 239000008184 oral solid dosage form Substances 0.000 abstract 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 71
- 239000000203 mixture Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 229910052573 porcelain Inorganic materials 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 150000003306 rutin derivatives Chemical class 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- MQGKFAGKLNYJRE-UHFFFAOYSA-N Anhydroalkannin Natural products CC(=CC=CC1=CC(=O)c2c(O)ccc(O)c2C1=O)C MQGKFAGKLNYJRE-UHFFFAOYSA-N 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical class OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical class C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000021289 health related food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 125000003748 selenium group Chemical class *[Se]* 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an oral rutin chewing agent and a method for preparing the same. The rutin chewing agent comprises 1 to 50 percent of rutin, 20 to 96 percent of thinner, 2 to 50 percent of vitamin C and 0 to 10 percent of additive. The invention also provides a method for preparing rutin chewing powder, a rutin chewing particle and a rutin chewing tablet. The method for preparing the rutin chewing agent comprises the following steps that: hydrophilic auxiliary materials are used as a main thinner; and by adopting the advanced preparation technology, the rutin is highly dispersed in the materials, so that the solubility of the rutin in water is increased, the dissolution rate is quick, and the biological utilization rate is improved. Compared with the conventional rutin oral solid dosage form, the rutin chewing agent has the advantages of high oral biological utilization rate and good taste, and easy acceptance by a patient, improving the compliance of the patient on taking the drug and facilitating the absorption. Moreover, the chewing agent is firstly chewed into fine powder in the mouth, thereby increasing the dissolving and dispersing rates of the active ingredients. Therefore, the chewing agent is suitable to be used by the patient suffering the dysphagia.
Description
Technical field
The present invention relates to a kind of oral rutin chewing agent and preparation method thereof.
Background technology
Rutin has another name called rutin sophorin, is a kind of active ingredient of natural plant with extensive physiologically active.Rutin can be strengthened ascorbic effect, promotes vitamin C to put aside in vivo, and the human body lipid cholesterol is reduced; Rutin is kept the normal resistance of capillary, reduces permeability, reduces the effect of its fragility, can prevent and treat hypertension.Rutin can also suppress hematoblastic gathering, prevents thrombosis, can resist simultaneously the injury of blood vessel that 5 one hydroxytryptamines, bradykinin cause, can prevent the oedema that vasopermeability raises and causes.In addition, rutin Anhydroalkannin, diuresis, antiallergy have significantly antitumor, anti-oxidant and influence effect such as various enzymatic activitys, are the important component in the Chinese herbal medicine for preventing prescription.
Rutin is present in the plant of multiple integration of drinking and medicinal herbs, like buckwheat, the sophora bud, asparagus, red date etc., for the development and use of rutin provide wide natural resources.The rutin side effect is little, in the disease treatment process, is bringing into play the complex treatment effect and the overall efficiency of multipath, many target spots, has the incomparable advantage of Western medicine, can be used as health food or medicine and uses.Clinically, rutin is used to treat cardiovascular and cerebrovascular diseases such as hypertension, cerebral hemorrhage, also can prevent and treat diabetes and reducing blood lipid simultaneously.
At present, having multiple on the market is the health products and the medicine sale of functional component with the rutin, like buckwheat tea in bag, rutin parenteral solution, rutin tablets and rutin sustained release preparation etc.Health-related food preparation technology is comparatively coarse, and active constituent content wherein is low, a little less than the health care and therapeutic action relatively to disease; Injection is inconvenient because of method of administration, be used for the emergency and severe disease patient more, limited its suffer from chronic disease, application among the crowd that need take medicine for a long time; Oral solid formulation such as tablet, granule, sustained release tablets etc. can reach the purpose of slowly-releasing or quick-release through the auxiliary material of packaging technique or use different performance because medication conveniently, is easy to carry about with one and transports, and medicine stability is high, become application formulation the most widely.Rutin is mainly used in chronic diseases such as treatment cardiovascular and cerebrovascular disease, diabetes, and oral solid formulation is its suitable formulation, but because of the rutin poorly water-soluble, oral administration biaavailability is low, makes the clinical therapeutic efficacy of this type preparation unsatisfactory.
Summary of the invention
The object of the present invention is to provide a kind of mouthfeel good, the rutin bioavilability is high, is beneficial to rutin chewing agent of absorption and preparation method thereof.
A kind of rutin chewing agent is characterized in that: comprise rutin 1%-50% in the said masticatory, diluent 20%-96%, vitamin C 2%-50% and additive 0%-10%.
Scheme further is: described additive is one or more in flavouring, lubricant, wetting agent and the adhesive.
Scheme further is: described flavouring is one or more in peppermint oil, orange oil, caryophyllus oil, oil of ginger, flavoring orange essence, lemon extract, strawberry essence, cherry essence, flavoring banana essence, syrup, sucrose, honey, xylitol, maltose, stevioside, the aspartame; Said lubricant is one or more in stearic acid, dolomol, calcium stearate, talcum powder, hydrogenated vegetable oil, polyethylene glycol, lauryl sodium sulfate, Stepanol MG, the superfine silica gel powder; Said wetting agent is water and the fused solution of ethanol; Said adhesive is to comprise a kind of in PVP, cellulose family adhesive, starch slurry, syrup, the rubber cement.
Scheme further is: comprise rutin 2%-30% in the said masticatory, diluent 40%-90%, vitamin C 4%-30% and additive 0.1%-8%.
Scheme further is: said diluent is one or more in sweet mellow wine, lactose, glucose, sorbierite, sucrose, microcrystalline cellulose, starch, dextrin and the pregelatinized starch.
Scheme further is: described rutin chewing agent is that rutin chews powder.
A kind ofly prepare the method that above-mentioned rutin chews powder, it is characterized in that passing through successively step 1 to step 3:
Step 1 is got 1%-50% rutin and 2%-50% vitamin C, pulverizes, and crosses 100 mesh sieves;
Step 2 adds 20%-93% diluent, 1%-5% flavouring and 0.1%-3% lubricant, mixes;
Step 3 sub-dose packaging.
Scheme further is: described rutin chewing agent is that rutin chews granule.
A kind ofly prepare the method that rutin chews granule, it is characterized in that passing through successively step 4 to step 10:
Step 4 is got 1%-50% rutin, 2%-50% vitamin C, 20%-93% diluent, 1%-5% flavouring, pulverizes, and crosses 80 mesh sieves;
Step 5 mixes rutin and vitamin C, diluent and flavouring, makes its high degree of dispersion in material;
Step 6 adds an amount of wetting agent or adhesive, processes softwood;
Step 7 softwood is crossed 14 mesh sieves, makes wet granular;
Step 8 is at 50-70 ℃ of following dry wet particle 0.5-2h;
Step 9 is got dried particle, sieve whole grain, classification;
Step 10 adds the 0.1%-3% lubricant, sub-dose packaging behind the mixing.
Scheme further is: described rutin chewing agent is the rutin chewable tablets.
A kind of method for preparing the rutin chewable tablets is characterized in that passing through successively step 11 to step 15:
Step 11 is got 1%-50% rutin, 2%-50% vitamin C, 20%-93% diluent, pulverizes, and crosses 80 mesh sieves;
Step 12 is even with rutin, vitamin C, mixing diluents, and rutin is dispersed in the material;
Step 13 is got the 0.1%-3% lubricant, pulverizes, and cross 100 mesh sieves and add in the mixture, and abundant mixing;
Step 14 adds 0.5%-2% aromatic, mixing, airtight 2-4 hour;
Step 15 compressing tablet;
A kind of method for preparing the rutin chewable tablets is characterized in that passing through successively step 16 to step 23:
Step 16 is got 1%-50% rutin, 2%-50% vitamin C, 20%-93% diluent, 1%-5% flavouring, pulverizes, and crosses 80 mesh sieves;
Step 17 is with the abundant mixing of rutin, vitamin C, diluent and flavouring;
Step 18 adds an amount of wetting agent or adhesive, the preparation softwood;
Step 19 softwood is crossed 14 mesh sieves, makes wet granular;
Step 20 is at 50-70 ℃ of following dry wet particle 0.5-2h, and the control moisture is at 1%-3%;
The dried particle of step 21 is crossed the whole grain of 16 mesh sieves;
Step 22 is got the 0.1%-3% lubricant, crosses 100 mesh sieves and adds in the dried particle mixing;
Step 23 compressing tablet.
Said rutin comprises that purity is greater than 70% rutin raw material, the active component that comprises rutin and the rutin derivatives that from plant, extract.
Said rutin derivatives refers to the rutin to be salt, ester, rutin of the rutin of main active and compound or complex compound, structure of modification product and the analyte that other compound forms.
The salt of said rutin comprises sodium salt, sylvite, calcium salt, zinc salt, selenium salt of rutin etc.
Said rutin ester comprises rutin acetic acid esters, formic acid esters, malate, propionic ester, citrate etc.
Said rutin also comprises the combination of rutin and other drug.
Rutin chewing agent of the present invention, with hydrophilicity condiment as main diluent; Adopt advanced preparation technique to make the rutin high degree of dispersion in material, thereby increase the solubility of rutin in water, dissolution rate is accelerated, and bioavilability improves.
Compare with traditional rutin oral dosage form, rutin chewing agent of the present invention is except that oral administration biaavailability is higher relatively, and other has following advantage: 1) mouthfeel is good, is prone to accepted by the patient, has increased the compliance of patient's medication; 2) be beneficial to absorption.Masticatory at first need be chewed into fine powder in the oral cavity, increased the speed of active ingredient dissolving and diffusion; 3) be suitable for having the patient of aphetite disorder to use.
The practical implementation method
Through the practical implementation instance, can further understand the present invention, but following instance is not a limitation of the present invention.
Embodiment 1
Rutin chews the preparation of particle (1)
Rutin 100g, sweet mellow wine 450g, lactose 450g, flavoring orange essence 1g.Get rutin, sweet mellow wine, lactose, flavoring orange essence, pulverize, cross 80 mesh sieves, put and grind 10min in the beveller and make fully and mix; With 3%PVP ethanolic solution system softwood, cross 14 mesh sieves, get wet granular, wet granular is tiled on the porcelain dish; Thickness is no more than 3mm, and dry 30min under 60 ℃ crosses No. 1 sieve and No. 5 sieves respectively and carries out whole grain and classification; Add 1% talcum powder, mixing, sub-dose packaging in the particle.
Embodiment 2
Rutin chews the preparation of particle (2)
Rutin 100g, sweet mellow wine 300g, xylitol 100g, vitamin C 100g, lactose 350g, glucose 50g.Get rutin, sweet mellow wine, xylitol, vitamin C, lactose, glucose, pulverize, cross 80 mesh sieves, put and grind 10min in the beveller and make fully and mix; With 20% ethanolic solution system softwood, cross 14 mesh sieves, get wet granular, wet granular is tiled on the porcelain dish; Thickness is no more than 3mm, and dry 1h under 60 ℃ crosses No. 1 sieve and No. 5 sieves respectively and carries out whole grain and classification; Add 1% talcum powder, mixing, sub-dose packaging in the particle.
Embodiment 3
Rutin chews the preparation of powder
Rutin 100g, xylitol 100g, vitamin C 100g, lactose 700g.Get rutin and vitamin C, pulverize, cross 100 mesh sieves, add xylitol, by equivalent progressively increase method and lactose mixing, sub-dose packaging.
Embodiment 4
The preparation of rutin chewable tablets
Rutin 100g, sweet mellow wine 300g, xylitol 100g, vitamin C 100g, lactose 400g, flavoring orange essence 1g.Get rutin, sweet mellow wine, xylitol, vitamin C, lactose, flavoring orange essence, pulverize, cross 80 mesh sieves, put and grind 10min in the beveller and make fully and mix; With 20% ethanolic solution system softwood, cross 14 mesh sieves, get wet granular, wet granular is tiled on the porcelain dish; Thickness is no more than 3mm, and dry 1h under 60 ℃ is with the whole grain of 16 mesh sieves; Add 1% talcum powder, mixing, compressing tablet.
Adopt that " 2005 editions two appendix XC dissolution methods of Chinese pharmacopoeia, one method has been measured the dissolution rate of rutin chewable tablets, and rotating speed is 100rmin
-1, the result sees table 1.
The dissolution rate of table 1 rutin chewable tablets
Can be found out that by table 1 rutin in the chewable tablets is in 1h stripping basically, assimilation effect is better.
Claims (2)
1. preparation method that rutin chews particle is characterized in that passing through successively step 4 to step 10:
Step 4 is got 1%-50% rutin, 2%-50% vitamin C, 20%-93% diluent, 1%-5% flavouring, pulverizes, and crosses 80 mesh sieves;
Step 5 mixes rutin and vitamin C, diluent and flavouring, makes its high degree of dispersion in material;
Step 6 adds an amount of wetting agent or adhesive, processes softwood;
Step 7 softwood is crossed 14 mesh sieves, makes wet granular;
Step 8 is at 50-70 ℃ of following dry wet particle 0.5-2h;
Step 9 is got dried particle, sieve whole grain, classification;
Step 10 adds the 0.1%-3% lubricant, sub-dose packaging behind the mixing;
Described flavouring is one or more in peppermint oil, orange oil, caryophyllus oil, oil of ginger, flavoring orange essence, lemon extract, strawberry essence, cherry essence, flavoring banana essence, syrup, sucrose, honey, xylitol, maltose, stevioside, the aspartame; Said wetting agent is water and the fused solution of ethanol;
Said lubricant is one or more in talcum powder, hydrogenated vegetable oil, polyethylene glycol, lauryl sodium sulfate, Stepanol MG, the superfine silica gel powder;
Said adhesive is to comprise a kind of in PVP, syrup, the rubber cement;
Said diluent is one or more in sweet mellow wine, lactose, glucose, sorbierite, sucrose, microcrystalline cellulose, the dextrin.
2. the preparation method of a rutin chewable tablets is characterized in that passing through successively step 16 to step 23:
Step 16 is got 1%-50% rutin, 2%-50% vitamin C, 20%-93% diluent, 1%-5% flavouring, pulverizes, and crosses 80 mesh sieves;
Step 17 is with the abundant mixing of rutin, vitamin C, diluent and flavouring;
Step 18 adds an amount of wetting agent or adhesive, the preparation softwood;
Step 19 softwood is crossed 14 mesh sieves, makes wet granular;
Step 20 is at 50-70 ℃ of following dry wet particle 0.5-2h, and the control moisture is at 1%-3%;
The dried particle of step 21 is crossed the whole grain of 16 mesh sieves;
Step 22 is got the 0.1%-3% lubricant, crosses 100 mesh sieves and adds in the dried particle mixing;
Step 23 compressing tablet;
Described flavouring is one or more in peppermint oil, orange oil, caryophyllus oil, oil of ginger, flavoring orange essence, lemon extract, strawberry essence, cherry essence, flavoring banana essence, syrup, sucrose, honey, xylitol, maltose, stevioside, the aspartame; Said lubricant is one or more in talcum powder, hydrogenated vegetable oil, polyethylene glycol, lauryl sodium sulfate, Stepanol MG, the superfine silica gel powder;
Said wetting agent is water and the fused solution of ethanol;
Said adhesive is to comprise a kind of in PVP, syrup, the rubber cement;
Said diluent is one or more in sweet mellow wine, lactose, glucose, sorbierite, sucrose, microcrystalline cellulose, the dextrin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100589496A CN101543298B (en) | 2009-04-15 | 2009-04-15 | Rutin chewing agent and method for preparing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100589496A CN101543298B (en) | 2009-04-15 | 2009-04-15 | Rutin chewing agent and method for preparing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101543298A CN101543298A (en) | 2009-09-30 |
| CN101543298B true CN101543298B (en) | 2012-08-08 |
Family
ID=41190879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100589496A Expired - Fee Related CN101543298B (en) | 2009-04-15 | 2009-04-15 | Rutin chewing agent and method for preparing same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101543298B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102511816A (en) * | 2012-01-06 | 2012-06-27 | 河南工业大学 | Technology for processing chewable (buccal) Chinese yam tablets |
| CN103141787B (en) * | 2013-04-07 | 2014-08-13 | 韩金光 | Acerola cherry preparation and preparation method thereof |
| CN105616436A (en) * | 2016-03-04 | 2016-06-01 | 刘勇 | Application of rutoside in preparation of osteosarcoma treating drug |
| CN106820111A (en) * | 2016-12-22 | 2017-06-13 | 四川天源油橄榄有限公司 | A kind of health product of Sunset Abelmoschus Root olive and preparation method thereof |
-
2009
- 2009-04-15 CN CN2009100589496A patent/CN101543298B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101543298A (en) | 2009-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2509477C1 (en) | New sweeteners compositions | |
| CN101352449B (en) | Vitamin orally disintegrating tablet and preparation method thereof | |
| US20050155519A1 (en) | Granulation process | |
| US20110177175A1 (en) | Dietary fiber compositions | |
| KR101471922B1 (en) | The method for manufacturing of tea | |
| TW201223522A (en) | Formulations | |
| CN101543298B (en) | Rutin chewing agent and method for preparing same | |
| JP4689468B2 (en) | Tablet and production method thereof | |
| JP2016174616A (en) | Disintegrable composition, and easily disintegrable compression molding | |
| CN106999600B (en) | Disintegrating granule composition comprising crushed lactose or granulated lactose | |
| US20170165315A1 (en) | Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population | |
| US20140031422A1 (en) | Compositions and Methods for Treating Bruises | |
| CN1425413A (en) | Xiasangju effervescent tablet and its preparing process | |
| CN101011451A (en) | Naoxinqing chewing tablet and its preparation process | |
| US11154585B2 (en) | Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population | |
| CN114209659A (en) | Vitamin C sustained-release direct drinking powder and preparation method thereof | |
| CN100542520C (en) | Yinqiao Detoxification Effervescent Tablets | |
| CN101496818B (en) | Kidney bone chewable tablet and preparation method thereof | |
| CN112754018A (en) | Vitamin bubble buccal tablet and preparation method thereof | |
| CN104814436A (en) | Ulvaceae functional oligosaccharide composite chewable tablet | |
| CN1957938B (en) | Effervescence tablet of Glucurolactone, and preparation method | |
| CN100387226C (en) | A stepahin orally disintegrating tablet and preparation method thereof | |
| KR101621502B1 (en) | A preparation method of an effervescent preparation comprising an extract of saengmacksan prescription | |
| CN114028504B (en) | Compound whole grain chewable tablet with hypoglycemic, lipid-lowering, and blood-pressure-lowering functions and its preparation method and application | |
| WO2013074046A1 (en) | Pharmaceutical formulations comprising isoflavone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120808 Termination date: 20160415 |